These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36742277)

  • 1. Clinicopathological and laboratory parameters of plasma cell leukemia among Indian population.
    Dubey H; Goel H; Verma S; Gupta S; Tanwar K; Rahul E; Kapoor G; Vasantharaman J; Ranjan A; Tanwar P; Chopra A
    Am J Blood Res; 2022; 12(6):190-195. PubMed ID: 36742277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study.
    Wang H; Zhou H; Zhang Z; Geng C; Chen W
    Turk J Haematol; 2020 May; 37(2):91-97. PubMed ID: 31769277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Center Experience of Patients with Plasma Cell Leukemia in the Era of New Therapeutics.
    Dampmann M; Flossdorf S; Keyl J; Reinhardt HC; Hanoun C
    Acta Haematol; 2024 May; ():1-8. PubMed ID: 38763126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor outcome despite modern treatments: A retrospective study of 99 patients with primary and secondary plasma cell leukemia.
    Tessier C; LeBlanc R; Roy J; Trudel S; Côté J; Lalancette M; Boudreault JS; Lemieux-Blanchard É; Kaedbey R; Pavic M
    Cancer Med; 2024 Sep; 13(17):e70192. PubMed ID: 39225552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Cytogenetic Profile of Primary and Secondary Plasma Cell Leukemia: Etiopathogenetic Perspectives, Prognostic Impact and Clinical Relevance to Newly Diagnosed Multiple Myeloma with Differential Circulating Clonal Plasma Cells.
    Papadhimitriou SI; Terpos E; Liapis K; Pavlidis D; Marinakis T; Kastritis E; Dimopoulos MA; Tsitsilonis OE; Kostopoulos IV
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic aberrations and survival in plasma cell leukemia.
    Tiedemann RE; Gonzalez-Paz N; Kyle RA; Santana-Davila R; Price-Troska T; Van Wier SA; Chng WJ; Ketterling RP; Gertz MA; Henderson K; Greipp PR; Dispenzieri A; Lacy MQ; Rajkumar SV; Bergsagel PL; Stewart AK; Fonseca R
    Leukemia; 2008 May; 22(5):1044-52. PubMed ID: 18216867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma cell leukemia in North India: retrospective analysis of a distinct clinicohematological entity from a tertiary care center and review of literature.
    Bommannan K; Sachdeva MU; Malhotra P; Kumar N; Sharma P; Naseem S; Ahluwalia J; Das R; Varma N; Prakash G; Khadwal A; Srinivasan R; Varma S
    Blood Res; 2016 Mar; 51(1):23-30. PubMed ID: 27104188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic profile of primary plasma cell leukemia in Korea: comparison with plasma cell myeloma.
    Lee Y; Yun J; Jeong D; Ryu S; Kwon SR; Yun H; Kim SM; Park JH; Lee DS
    Leuk Lymphoma; 2022 Feb; 63(2):385-394. PubMed ID: 34592901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomics of Plasma Cell Leukemia.
    Rojas EA; Gutiérrez NC
    Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinico-pathological spectrum of primary plasma cell leukemia diagnosed at a tertiary care centre in South India over 5 year period.
    Kar R; Priyadarshini SG; Niraimathi M; Basu D; Badhe BA
    Indian J Hematol Blood Transfus; 2012 Sep; 28(3):170-4. PubMed ID: 23997454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell leukemia: a rare condition.
    Jiménez-Zepeda VH; Domínguez VJ
    Ann Hematol; 2006 Apr; 85(4):263-7. PubMed ID: 16416115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired del(9)(p22.3) in a primary plasma cell leukemia.
    Achkar WA; Wafa A; Aljapawe A; Othman MA; Alhourani E; Liehr T
    Mol Cytogenet; 2013 Aug; 6(1):33. PubMed ID: 23985162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical Characteristics and Survival Analysis of Patients with Plasma Cell Leukemia].
    Wang SF; Qin XQ; Guo QH; Wang JY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):693-698. PubMed ID: 37356928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Current State of Knowledge About Evolution of Multiple Myeloma to Plasma Cell Leukemia.
    Jurczyszyn A; Olszewska-Szopa M; Vesole DH
    Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):188-193. PubMed ID: 36593169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
    Katodritou E; Terpos E; Kelaidi C; Kotsopoulou M; Delimpasi S; Kyrtsonis MC; Symeonidis A; Giannakoulas N; Stefanoudaki A; Christoulas D; Chatziaggelidou C; Gastari V; Spyridis N; Verrou E; Konstantinidou P; Zervas K; Dimopoulos MA
    Am J Hematol; 2014 Feb; 89(2):145-50. PubMed ID: 24123068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and outcomes of plasma cell leukemia: a single-institution experience in the era of novel agents.
    Talamo G; Dolloff NG; Sharma K; Zhu J; Malysz J
    Rare Tumors; 2012 Jun; 4(3):e39. PubMed ID: 23087795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia.
    Chang H; Qi X; Yeung J; Reece D; Xu W; Patterson B
    Leuk Res; 2009 Feb; 33(2):259-62. PubMed ID: 18676019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis].
    Jurczyszyn A; Zawirska D; Skotnicki AB
    Przegl Lek; 2011; 68(6):320-5. PubMed ID: 22039670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis.
    Jimenez-Zepeda VH; Dominguez-Martinez VJ
    Int J Hematol; 2009 Apr; 89(3):259-268. PubMed ID: 19326058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.